Skip to main content
Clinical Trials/NL-OMON38812
NL-OMON38812
Withdrawn
Not Applicable

Prospective cohort study of COPD patients from Maastricht area: the Maastricht COPD Cohort (MCC) - Maastricht COPD Cohort

CIRO+, expertisecentrum voor chronisch orgaanfalen0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
chronic bronchitis
Sponsor
CIRO+, expertisecentrum voor chronisch orgaanfalen
Enrollment
200
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
CIRO+, expertisecentrum voor chronisch orgaanfalen

Eligibility Criteria

Inclusion Criteria

  • \- Adults, either sex, older than 40 years of age;
  • \- Smoking history of 10 Pack Years or more;
  • \- Diagnosis of COPD stages I\-IV as defined by the Global initiative for chronic Obstructive Lung Disease (GOLD);
  • \- Classified by COPD severity in group B or D, based on the GOLD criteria of COPD severity (Figure 1\);
  • \- Patients must be able to complete diaries and quality of life questionnaires;
  • \- Patients must sign and date an informed consent prior to inclusion in the MCC.

Exclusion Criteria

  • \- Progressively fatal disease, or life expectancy \*6 months;
  • \- Women who are breast feeding or are pregnant;
  • \- Patients with mental conditions rendering them unable to understand the nature, scope, and possible consequences of the study;
  • \- Patients unlikely to comply with the protocol, e.g., uncooperative attitude, inability to return for follow\-up visits, and unlikelihood of completing the study;
  • \- Patients participating in an intervention study.

Outcomes

Primary Outcomes

Not specified

Similar Trials